🇺🇸 FDA
Patent

US 8877797

Methods for treating Parkinson's disease using pro-neurogenic compounds

granted A61KA61K31/403A61K31/4439

Quick answer

US patent 8877797 (Methods for treating Parkinson's disease using pro-neurogenic compounds) held by The Board of Regents of the University of Texas System expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/403, A61K31/4439, A61P, A61P25/08